?? StartUp Health company Sen-Jam Pharmaceutical advances their FDA-regulated hangover prevention therapy tackling inflammation to Phase 2 clinical trials. A previous pilot study examining the company’s SJP-001 compound found it was able to cut hangover symptoms such as headaches, nausea, and dizziness. #HealthTransformer #HealthMoonshot https://ow.ly/fEw850UazA7
